OBJECTIVE: To compare magnetic resonance (MR) signal characteristics of contrast agent-labeled apoptotic and viable human mesenchymal stem cells (hMSCs) in matrix-associated stem cell implants. METHODS: hMSCs were labeled with Food and Drug Administration-approved ferumoxides nanoparticles. One group (A) remained untreated whereas a second group (B) underwent mitomycin C-induced apoptosis induction. Viability of group A and apoptosis of group B was confirmed by caspase-assays and terminal dUTP nick-end labeling (TUNEL) stains. Labeled viable hMSCs, unlabeled viable hMSCs, labeled apoptotic hMSCs, and unlabeled apoptotic hMSCs (n = 7 samples each) in an agarose scaffold were implanted into cartilage defects of porcine patellae specimens and underwent MR imaging at 7 T, using T1-weighted spin-echo sequences, T2-weighted spin-echo sequences, and T2*-weighted gradient-echo sequences. Signal-to-noise ratios (SNR) of the implants were calculated and compared between different experimental groups using linear mixed regression models. RESULTS: Ferumoxides-labeled hMSCs provided a strong negative T2 and T2*-enhancement. Corresponding SNR data of labeled hMSCs were significantly lower compared with unlabeled controls (P < 0.05). Apoptosis induction resulted in a significant signal decline of ferumoxides-labeled hMSC transplants on short echo time T2-weighted spinecho sequences. SNR data of labeled apoptotic hMSCs were significantly lower compared with labeled viable hMSCs (P < 0.05). CONCLUSION: Apoptosis of transplanted ferumoxides-labeled stem cells in cartilage defects can be visualized noninvasively by a significant signal decline on T2-weighted MR images. The described MR signal characteristics may serve as a noninvasive outcome measure for the assessment of matrix-associated stem cell implants in clinical practice. Additional studies are needed to further enhance the observed differences between viable and apoptotic cells, for example, by further optimizing the applied MR pulse sequence parameters or intracellular contrast agent concentration.
OBJECTIVE: To compare magnetic resonance (MR) signal characteristics of contrast agent-labeled apoptotic and viable human mesenchymal stem cells (hMSCs) in matrix-associated stem cell implants. METHODS: hMSCs were labeled with Food and Drug Administration-approved ferumoxides nanoparticles. One group (A) remained untreated whereas a second group (B) underwent mitomycin C-induced apoptosis induction. Viability of group A and apoptosis of group B was confirmed by caspase-assays and terminal dUTP nick-end labeling (TUNEL) stains. Labeled viable hMSCs, unlabeled viable hMSCs, labeled apoptotic hMSCs, and unlabeled apoptotic hMSCs (n = 7 samples each) in an agarose scaffold were implanted into cartilage defects of porcine patellae specimens and underwent MR imaging at 7 T, using T1-weighted spin-echo sequences, T2-weighted spin-echo sequences, and T2*-weighted gradient-echo sequences. Signal-to-noise ratios (SNR) of the implants were calculated and compared between different experimental groups using linear mixed regression models. RESULTS:Ferumoxides-labeled hMSCs provided a strong negative T2 and T2*-enhancement. Corresponding SNR data of labeled hMSCs were significantly lower compared with unlabeled controls (P < 0.05). Apoptosis induction resulted in a significant signal decline of ferumoxides-labeled hMSC transplants on short echo time T2-weighted spinecho sequences. SNR data of labeled apoptotic hMSCs were significantly lower compared with labeled viable hMSCs (P < 0.05). CONCLUSION: Apoptosis of transplanted ferumoxides-labeled stem cells in cartilage defects can be visualized noninvasively by a significant signal decline on T2-weighted MR images. The described MR signal characteristics may serve as a noninvasive outcome measure for the assessment of matrix-associated stem cell implants in clinical practice. Additional studies are needed to further enhance the observed differences between viable and apoptotic cells, for example, by further optimizing the applied MR pulse sequence parameters or intracellular contrast agent concentration.
Authors: Philipp Niemeyer; Jan M Pestka; Peter C Kreuz; Christoph Erggelet; Hagen Schmal; Norbert P Suedkamp; Matthias Steinwachs Journal: Am J Sports Med Date: 2008-09-18 Impact factor: 6.202
Authors: Laura E Edgington; Alicia B Berger; Galia Blum; Victoria E Albrow; Margot G Paulick; Neil Lineberry; Matthew Bogyo Journal: Nat Med Date: 2009-07-13 Impact factor: 53.440
Authors: Tobias D Henning; Michael F Wendland; Daniel Golovko; Elizabeth J Sutton; Barbara Sennino; Farbod Malek; Jan S Bauer; Donald M McDonald; Heike Daldrup-Link Journal: Magn Reson Med Date: 2009-08 Impact factor: 4.668
Authors: Tobias D Henning; Elizabeth J Sutton; Anne Kim; Daniel Golovko; Andrew Horvai; Larry Ackerman; Barbara Sennino; Donald McDonald; Jeffrey Lotz; Heike E Daldrup-Link Journal: Contrast Media Mol Imaging Date: 2009 Jul-Aug Impact factor: 3.161
Authors: Markus T Berninger; Pouyan Mohajerani; Melanie Kimm; Stephan Masius; Xiaopeng Ma; Moritz Wildgruber; Bernhard Haller; Martina Anton; Andreas B Imhoff; Vasilis Ntziachristos; Tobias D Henning; Reinhard Meier Journal: Eur Radiol Date: 2016-06-21 Impact factor: 5.315
Authors: Lauren R Eichaker; Hongsik Cho; Craig L Duvall; Thomas A Werfel; Karen A Hasty Journal: Nanomedicine (Lond) Date: 2014-07 Impact factor: 5.307
Authors: Tobias D Henning; Rakhee Gawande; Aman Khurana; Sidhartha Tavri; Lydia Mandrussow; Daniel Golovko; Andrew Horvai; Barbara Sennino; Donald McDonald; Reinhard Meier; Michael Wendland; Nikita Derugin; Thomas M Link; Heike E Daldrup-Link Journal: Mol Imaging Date: 2012-06 Impact factor: 4.488
Authors: Aman Khurana; Fanny Chapelin; Graham Beck; Olga D Lenkov; Jessica Donig; Hossein Nejadnik; Solomon Messing; Nikita Derugin; Ray Chun-Fai Chan; Amitabh Gaur; Barbara Sennino; Donald M McDonald; Paul J Kempen; Grigory A Tikhomirov; Jianghong Rao; Heike E Daldrup-Link Journal: Radiology Date: 2013-07-12 Impact factor: 11.105